Hong Kong’s biotech listings initiative struggles to take off

Karry Lai

January 24, 2019

X
LinkedIn
Email
Show more sharing options

Regulators are keen to attract new companies, but investor protection measures must be improved, according to HK-based fund managers and regulators

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

Karry Lai

Managing editor

Karry is managing editor of IFLR. She manages the team and is responsible for IFLR's content. She also sits on the editorial judging panels of IFLR's global awards and the Women in Business Law Awards. Before joining the legal media industry, she was project manager at a startup focused on sustainable lifestyle media and events.